Premium
Automated Peritoneal Dialysis Symposium: APD Prescription: Achieving the Adequacy Goals
Author(s) -
Dell'Aquila Roberto,
Rodighiero Maria Pia,
Bordoni Valeria,
D'Intini Vincente,
Ronco Claudio
Publication year - 2002
Publication title -
seminars in dialysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 78
eISSN - 1525-139X
pISSN - 0894-0959
DOI - 10.1046/j.1525-139x.2002.00099.x
Subject(s) - medicine , peritoneal dialysis , modalities , medical prescription , treatment modality , ultrafiltration (renal) , dialysis , peritoneal equilibration test , intensive care medicine , creatinine , biomedical engineering , pharmacology , continuous ambulatory peritoneal dialysis , social science , chemistry , chromatography , sociology
In the last few years, automated peritoneal dialysis (APD) has undergone considerable improvements due to technological developments. The definition of a minimal dose of peritoneal dialysis (PD) has not yet been completely assessed. Appropriate use of APD requires an evaluation of dialytic efficiency in terms of dialytic indexes and their targets. Many dialytic treatment modalities have been performed in order to achieve adequacy targets. Some aspects have to be taken into consideration to reach the optimal dialytic dose: optimizing mass transfer in correlation with intraperitoneal volumes, prescribing tailored treatment modalities according to different characteristics of peritoneal membranes and individual patient needs, and performing more biocompatible treatments using different glucose profiling and alternative physiologic PD fluids. New high‐flow techniques such as continuous flow PD can ensure better urea and creatinine clearances and ultrafiltration rates, leading to a higher utilization of the APD modality.